Literature DB >> 5284834

Diabetes in patients treated with asparaginase.

S Gailani, A Nussbaum, T Onuma, A Freeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5284834     DOI： 10.1002/cpt1971123487

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

Review 1.  Antineoplastic and immunosuppressive drugs. 3. Adverse effects and therapeutic problems.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  The effect of E. coli L-asparaginase on oral glucose tolerance and insulin release in man.

Authors:  R L Lavine; I Brodsky; C D Garofano; L I Rose
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

Review 3.  The role of environmental factors in insulin-dependent diabetes mellitus: an unresolved issue.

Authors:  M R Kraine; R M Tisch
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

4.  Diabetic ketoacidosis following PEG-asparaginase therapy

Authors:  Miriam Hinaa Ahmad; Ismat Shafiq
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.